<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
67457-257-02
</NDCCode>
<PackageDescription>
10 VIAL in 1 CARTON (67457-257-02) > 1 mL in 1 VIAL (67457-257-00)
</PackageDescription>
<NDC11Code>
67457-0257-02
</NDC11Code>
<ProductNDC>
67457-257
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Cosyntropin
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Cosyntropin
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, FOR SOLUTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR; INTRAVENOUS
</RouteName>
<StartMarketingDate>
20130508
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA090574
</ApplicationNumber>
<LabelerName>
Mylan Institutional LLC
</LabelerName>
<SubstanceName>
COSYNTROPIN
</SubstanceName>
<StrengthNumber>
.25
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes>
Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2018-03-05
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20181231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>